RxDoctor Payments Data

Geraldine Rodrigues-Pratt

Psychiatric/Mental Health · Jacksonville, FLNPI 1255499133

Payments from drug & device makers

$4,719in general payments, 2019–2025

Across 247 payments — averaging $19.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$982
  • AbbVie$685
  • Vanda Pharmaceuticals Inc.$444
  • Teva Pharmaceuticals USA, Inc.$292
  • Otsuka America Pharmaceutical, Inc.$291
  • Neurocrine Biosciences, Inc.$277
  • plus $2K from 17 others

What the payments were for

  • Food & beverage$4,66999%
  • Education$501%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,719 in reported general payments places this provider in the 85th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida

Medicare billing

Part B allowed, 2024
$26,915
Medicare patients
57
Services billed
252

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl17$29,734
TrintellixVortioxetine Hydrobromide11$13,464
Lurasidone Hcl13$12,584
Desvenlafaxine Succinate ErDesvenlafaxine Succinate62$4,306
Clozapine42$2,072
Quetiapine Fumarate81$1,949
Bupropion XlBupropion Hcl44$1,563
Ziprasidone Hcl17$1,327
Divalproex Sodium30$1,253
Oxcarbazepine16$1,217
Aripiprazole19$1,204
Olanzapine24$996
Clonazepam64$875
Vilazodone Hcl12$770
Trazodone Hcl48$749

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$685$29,73417 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$269$13,46411 claims
Almatica Pharma LLCSertraline Hcl$82$43756 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,096 psychiatric/mental health providers in Florida.

Other psychiatric/mental health in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →